Growth Metrics

Travere Therapeutics (TVTX) Net Income Growth (1y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 617,775.00%
Dec 31, 2024 100.25%
Sep 30, 2024 -100.02%
Jun 30, 2024 -104.64%
Mar 31, 2024 -101.01%
Dec 31, 2023 -107.96%
Sep 30, 2023 1,565.69%
Jun 30, 2023 25.49%
Mar 31, 2023 77.19%
Dec 31, 2022 122.32%
Sep 30, 2022 140.42%
Jun 30, 2022 133.30%
Mar 31, 2022 110.72%
Dec 31, 2021 27.01%
Sep 30, 2021 -58.05%
Jun 30, 2021 -49.65%
Mar 31, 2021 -6,765.10%
Dec 31, 2020 -301.94%
Sep 30, 2020 38.20%
Jun 30, 2020 32.64%
Mar 31, 2020 101.97%
Dec 31, 2019 -305.89%
Sep 30, 2019 33.07%
Jun 30, 2019 -73.32%
Mar 31, 2019 -122.97%
Dec 31, 2018 57.69%
Sep 30, 2018 -206.37%
Jun 30, 2018 -68.79%
Mar 31, 2018 -65.72%
Dec 31, 2017 -104.79%
Sep 30, 2017 52.05%
Jun 30, 2017 1.30%
Mar 31, 2017 -198.88%
Dec 31, 2016 -248.44%
Sep 30, 2016 -135.15%
Jun 30, 2016 47.49%
Mar 31, 2016 -71.72%
Dec 31, 2015 91.49%
Sep 30, 2015 687.20%
Jun 30, 2015 -316.24%
Mar 31, 2015 152.36%
Dec 31, 2014 -127.73%
Sep 30, 2014 -49.69%
Jun 30, 2014 339.77%
Mar 31, 2014 -1,455.82%
Aug 31, 2012 0.71%